RBC Capital Keeps Their Buy Rating on Next plc (NXT)
In a report released on January 21, Richard Chamberlain from RBC Capital maintained a Buy rating on Next plc (NXT – Research Report), with a ...
Axsome Therapeutics (AXSM) Gets a Buy from RBC Capital
RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) on January 21 and set a price ...
RBC Capital Sticks to Its Buy Rating for Sarepta Therapeutics (SRPT)
In a report released on January 21, Brian Abrahams from RBC Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...
RBC Capital Reaffirms Their Buy Rating on Coursera (COUR)
In a report released on January 20, Rishi Jaluria from RBC Capital maintained a Buy rating on Coursera (COUR – Research Report), with a price ...
RBC Capital Sticks to Its Buy Rating for Five9 (FIVN)
In a report released on January 20, Rishi Jaluria from RBC Capital maintained a Buy rating on Five9 (FIVN – Research Report), with a price ...
RBC Capital Remains a Sell on 3M (MMM)
In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...
Nasdaq14d
Zions Bancorp price target lowered to $61 from $62 at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Nasdaq14d
Wintrust Financial price target raised to $152 from $148 at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Nasdaq14d
CIBC upgraded to Outperform from Sector Perform at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Nasdaq14d
Bank of Montreal upgraded to Outperform from Sector Perform at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Nasdaq14d
Affirm price target raised to $67 from $52 at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Nasdaq14d
Nike price target lowered to $70 from $80 at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...